review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Dario C Altieri | Q98158352 |
P2860 | cites work | A novel role for XIAP in copper homeostasis through regulation of MURR1 | Q24302274 |
P433 | issue | 6 | |
P921 | main subject | cell death | Q2383867 |
P304 | page(s) | 609-615 | |
P577 | publication date | 2006-08-24 | |
P1433 | published in | Current Opinion in Cell Biology | Q13505682 |
P1476 | title | The case for survivin as a regulator of microtubule dynamics and cell-death decisions | |
P478 | volume | 18 |
Q33748743 | 1,1-Bis(3'-indolyl)-1-(p-bromophenyl)methane and related compounds repress survivin and decrease gamma-radiation-induced survivin in colon and pancreatic cancer cells |
Q24336928 | A survivin-ran complex regulates spindle formation in tumor cells |
Q58780488 | Aberrantly Expressed Genes and miRNAs in Slow Transit Constipation Based on RNA-Seq Analysis |
Q38162230 | An APC:WNT Counter-Current-Like Mechanism Regulates Cell Division Along the Human Colonic Crypt Axis: A Mechanism That Explains How APC Mutations Induce Proliferative Abnormalities That Drive Colon Cancer Development |
Q39162217 | Anti-leukemic response of a NSAID, tolfenamic acid. |
Q39149869 | Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study. |
Q37145344 | Apoptosis in murine norovirus-infected RAW264.7 cells is associated with downregulation of survivin. |
Q42457508 | Basal endothelial nitric oxide synthase (eNOS) phosphorylation on Ser(1177) occurs in a stable microtubule- and tubulin acetylation-dependent manner. |
Q37078661 | Bir1 is required for the tension checkpoint |
Q38833708 | Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation |
Q39748970 | Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types |
Q42183993 | Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells. |
Q48221713 | Cerebrovascular effects of ischemic preconditioning: endothelial survivin joins the fray. |
Q46948861 | Changes in the expression of genes related to apoptosis and fibrosis pathways in CCl4-treated rats |
Q29620468 | Chromosomal passengers: conducting cell division |
Q33897748 | Cleavage of survivin by Granzyme M triggers degradation of the survivin-X-linked inhibitor of apoptosis protein (XIAP) complex to free caspase activity leading to cytolysis of target tumor cells |
Q37746154 | Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis |
Q39596491 | Combined effect of sCD40L and PI3K siRNA on transplanted tumours growth and microenvironment in nude mice with gastric cancer. |
Q92616966 | Combined induction with anti-PD-1 and anti-CTLA-4 antibodies provides synergistic antitumor effects in DC-CIK cells in renal carcinoma cell lines |
Q36002989 | Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection |
Q41992399 | Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer |
Q91142650 | Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma |
Q24302542 | Cytokine activation of p38 mitogen-activated protein kinase and apoptosis is opposed by alpha-4 targeting of protein phosphatase 2A for site-specific dephosphorylation of MEK3. |
Q39286256 | Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcription |
Q30484130 | Deconstructing Survivin: comprehensive genetic analysis of Survivin function by conditional knockout in a vertebrate cell line |
Q53293047 | Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression? |
Q42906957 | Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas |
Q39584334 | Downregulation of stathmin is involved in malignant phenotype reversion and cell apoptosis in esophageal squamous cell carcinoma |
Q33679446 | EGF regulates survivin stability through the Raf-1/ERK pathway in insulin-secreting pancreatic β-cells. |
Q33888082 | Evaluation of the Expression of the Inhibitor of Apoptosis Protein Family and Human Telomerase Reverse Transcriptase in Patients With Advanced Colorectal Adenoma |
Q41503180 | Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients. |
Q55399631 | Expression and clinical significance of survivin in ovarian cancer: A meta-analysis. |
Q36063654 | Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies |
Q36611508 | Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney. |
Q39871645 | Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential |
Q35024090 | Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo |
Q34362475 | Gradual recruitment and selective clearing generate germ plasm aggregates in the zebrafish embryo |
Q28590617 | Hepatoma-derived growth factor-related protein-3 interacts with microtubules and promotes neurite outgrowth in mouse cortical neurons |
Q53187326 | High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer. |
Q57286058 | Hippo signaling pathway is altered in Duchenne muscular dystrophy |
Q24303954 | Hsp60 regulation of tumor cell apoptosis |
Q37148694 | IAPs: what's in a name? |
Q34871780 | Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin |
Q40645812 | Increased survivin expression confers chemoresistance to tumor-associated endothelial cells |
Q39882683 | Induction of apoptosis of human colon cancer cells by siRNA recombinant expression vector targeting survivin gene |
Q40115775 | Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC. |
Q53749392 | Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss. |
Q36125103 | Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death |
Q38969264 | Inhibition of survivin restores the sensitivity of breast cancer cells to docetaxel and vinblastine. |
Q40254603 | Inhibitory effects of resveratrol on hepatitis B virus X-protein (HBx)-induced hepatocellular carcinoma (HCC). |
Q28386284 | Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivin |
Q39711810 | Intracellular targets of RGDS peptide in melanoma cells. |
Q92713114 | Krill oil extract suppresses the proliferation of colorectal cancer cells through activation of caspase 3/9 |
Q39852047 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation |
Q26799719 | Localization and upregulation of survivin in cancer health disparities: a clinical perspective |
Q28535017 | Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma |
Q38792887 | Lupeol enhances inhibitory effect of 5-fluorouracil on human gastric carcinoma cells |
Q54239289 | MYCN and survivin cooperatively contribute to malignant transformation of fibroblasts. |
Q36216225 | Marked upregulation of Survivin and Aurora-B kinase is associated with disease progression in the myelodysplastic syndromes |
Q26823048 | Megalin in acute kidney injury: foe and friend |
Q54795628 | Metachronous cancer development in patients with sporadic colorectal adenomas-multivariate risk model with independent and combined value of hTERT and survivin. |
Q30010065 | MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells |
Q34209054 | MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells |
Q27690249 | Microtubule-binding agents: a dynamic field of cancer therapeutics |
Q37146751 | Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance |
Q28482133 | Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma |
Q55445418 | Natural products: a hope for glioblastoma patients. |
Q37302750 | New wirings in the survivin networks |
Q36217015 | Nuclear factor-κB expression is predictive of overall survival in patients with cutaneous melanoma. |
Q36559689 | Nucleotide composition of cellular internal ribosome entry sites defines dependence on NF45 and predicts a posttranscriptional mitotic regulon |
Q40074702 | Oncogenic c-H-ras deregulates survivin expression: an improvement for survival |
Q35846374 | Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo |
Q33572996 | Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer |
Q36906366 | Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin |
Q41507351 | Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy |
Q35947272 | Prognostic relevance of survivin in pancreatic endocrine tumors |
Q44202978 | Protective effects of captopril in diabetic rats exposed to ischemia/reperfusion renal injury |
Q39395181 | Quantitative shape analysis of chemoresistant colon cancer cells: correlation between morphotype and phenotype. |
Q37689286 | Recent Advances on Small-Molecule Survivin Inhibitors. |
Q39704064 | Receptor activation and inhibition in cellular response to chemotherapeutic combinational mimicries: the concept of divergent targeting |
Q83309531 | SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin |
Q33652526 | Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter |
Q39672097 | Sensitization of Osteosarcoma Cell Line SaOS-2 to Chemotherapy by Downregulating Survivin |
Q40168320 | Significant impact of survivin on myeloma cell growth. |
Q36880450 | Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution |
Q34173886 | Suberoylanilide hydroxamic acid induces apoptosis and sub-G1 arrest of 320 HSR colon cancer cells |
Q34078474 | Survival responses of human embryonic stem cells to DNA damage |
Q26825700 | Survivin - The inconvenient IAP |
Q35414780 | Survivin and IAP proteins in cell-death mechanisms |
Q53293111 | Survivin and cycline D1 expressions are associated with malignant potential in mucinous ovarian neoplasms. |
Q38188377 | Survivin as a preferential target for cancer therapy |
Q36795237 | Survivin expression increases during aging and enhances the resistance of aged human fibroblasts to genotoxic stress |
Q41944319 | Survivin expression is associated with lens epithelial cell proliferation and fiber cell differentiation. |
Q34254214 | Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription |
Q37876468 | Survivin in skin pathologies |
Q37974867 | Survivin in solid tumors: rationale for development of inhibitors. |
Q35142549 | Survivin is a potential mediator of prostate cancer metastasis |
Q36079787 | Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML |
Q37262466 | Survivin is not required for the endomitotic cell cycle of megakaryocytes |
Q35217196 | Survivin is released from cancer cells via exosomes. |
Q34992551 | Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo. |
Q34234351 | Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells |
Q24301054 | Survivin monomer plays an essential role in apoptosis regulation |
Q55046676 | Survivin, cancer networks and pathway-directed drug discovery. |
Q37834973 | Survivin-T34A: molecular mechanism and therapeutic potential. |
Q37928907 | Survivin: a dual player in healthy and diseased skin |
Q37798272 | Survivin: a target from brain cancer to neurodegenerative disease. |
Q40139932 | Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells |
Q26821986 | Targeting caspases in cancer therapeutics |
Q28273083 | Targeting survivin in cancer therapy |
Q51749083 | Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein. |
Q39283577 | Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells |
Q41860863 | The CRM1 nuclear export protein in normal development and disease. |
Q42560434 | The Concept of Divergent Targeting through the Activation and Inhibition of Receptors as a Novel Chemotherapeutic Strategy: Signaling Responses to Strong DNA-Reactive Combinatorial Mimicries |
Q46603162 | The RanGTP gradient - a GPS for the mitotic spindle |
Q54987435 | The Rules and Functions of Nucleocytoplasmic Shuttling Proteins. |
Q33860510 | The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro |
Q27323285 | The chromosomal passenger protein birc5b organizes microfilaments and germ plasm in the zebrafish embryo |
Q34584439 | The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancer |
Q35810533 | The emerging role of exosomes in survivin secretion |
Q54332089 | The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables. |
Q27648318 | The mitotic regulator Survivin binds as a monomer to its functional interactor Borealin |
Q51864107 | The oncofetal gene survivin promotes cell proliferation and survival in primary human osteoblastic cells. |
Q44953594 | The process of apoptosis in a holocrine gland as shown by the avian uropygial gland |
Q28581878 | The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney |
Q39632401 | Tithonia diversifolia and its main active component tagitinin C induce survivin inhibition and G2/M arrest in human malignant glioblastoma cells |
Q39418496 | Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: a novel therapeutic agent for neuroblastoma |
Q100295393 | Unraveling novel survivin mRNA transcripts in cancer cells using an in-house developed targeted high-throughput sequencing approach |
Q36488146 | Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression |
Q36200492 | Yes-associated protein regulates the hepatic response after bile duct ligation |
Q53755710 | Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis. |
Q33810310 | Yin Yang 1 regulates the transcriptional repression of Survivin |
Q54334974 | [Effect of shRNA Survivin-mediated inhibition of proliferation in A549 cells]. |
Q33895595 | p53-Independent apoptosis by benzyl isothiocyanate in human breast cancer cells is mediated by suppression of XIAP expression |
Search more.